Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Cyclooxygenase-2 , comparison with

Visco, D., Girard, Y., Prasit, P., Zamboni, R., Rodger, I.W., Gresser, M., Ford-Hutchinson, A.W., Young, R.N., Chan, C.C. Etoricoxib (MK-0663) preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2, J. Pharmacol. Exp. Ther. 2001, 296, 558-566. [Pg.123]

Riendeau D, Percival D, Brideau C et al. (2001) Etoricoxib (MK-0663) Preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharm Exp Ther 296 558-566... [Pg.242]

Fig. 4.14. Structure of the biologically active isoprostane, 8-epi-PGF2 and comparison with the structure of the cyclooxygenase-derived product, PGFia ... Fig. 4.14. Structure of the biologically active isoprostane, 8-epi-PGF2 and comparison with the structure of the cyclooxygenase-derived product, PGFia ...
White WB, Faich G, Whelton A, Maurath C, Ridge NJ, Verburg KM, Geis GS, Lefkowith JB. Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac. Am J Cardiol 2002 89(4) 425-30. [Pg.1012]

Hawkey C, Laine L, Simon T, et al, for the Rofecoxib Osteoarthritis Endoscopy Multinational Study Group. Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis. Arthritis Rheum 2000 43 370-377. [Pg.1702]


See other pages where Cyclooxygenase-2 , comparison with is mentioned: [Pg.144]    [Pg.218]    [Pg.265]    [Pg.354]    [Pg.282]    [Pg.139]    [Pg.353]    [Pg.767]    [Pg.231]    [Pg.202]    [Pg.172]    [Pg.220]   


SEARCH



Cyclooxygenase

© 2024 chempedia.info